Successful treatment of cherry red spot—myoclonus syndrome with 5‐hydroxytryptophan
- 1 September 1988
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 24 (3) , 453-455
- https://doi.org/10.1002/ana.410240317
Abstract
A 14‐year‐old Saudi boy with cherry red spot‐myo‐clonus syndrome and documented neuraminidase deficiency responded well to titrated doses of 5‐hydroxy‐tryptophan as an add‐on treatment.Keywords
This publication has 9 references indexed in Scilit:
- A physiologic and pharmacologic study in anticholinergic‐responsive essential myoclonusNeurology, 1987
- Essential MyoclonusClinical Neuropharmacology, 1984
- Cherry-red spot myoclonus syndrome and alpha-neuraminidase deficiency: neurophysiological, pharmacological and biochemical study in an adult.Journal of Neurology, Neurosurgery & Psychiatry, 1980
- SIALIDOSIS - REVIEW OF HUMAN NEURAMINIDASE DEFICIENCY1979
- The cherry‐red spot‐myoclonus syndromeAnnals of Neurology, 1978
- Neuraminidase deficiency in the cherry red spot-myoclonus syndromeBiochemical and Biophysical Research Communications, 1977
- Electrophysiological Studies in Two Patients with Cherry Red Spot‐Myoclonus SyndromeEpilepsia, 1977
- Therapy of intention myoclonus with L‐5‐hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486Neurology, 1975
- A CASE OF JUVENILE LIPIDOSISJournal of Neuropathology and Experimental Neurology, 1963